KPIs & Operating Metrics(New)

Balance Sheet

Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased

Daily Values

Growth Metrics

Others

Accumulated Depreciation & Amortization Accumulated Depreciation & Amortization Cost of Revenue EBIAT Gross Profit Leases Long-Term Debt Issuances Long-Term Debt Repayments Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - Net Receivables - Other Shares Issued Shares Outstanding Shares Outstanding Shares Repurchased

Herbalife (HLF) Long-Term Debt Issuances (2017 - 2026)

Herbalife's Long-Term Debt Issuances history spans 14 years, with the latest figure at -$270.8 million for Q3 2025.

On a quarterly basis, Long-Term Debt Issuances fell 179.81% to -$270.8 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$339.3 million, a 125.46% decrease, with the full-year FY2024 number at $778.4 million, up 261.71% from a year prior.
Long-Term Debt Issuances hit -$270.8 million in Q3 2025 for Herbalife, down from $205.8 million in the prior quarter.
Over the last five years, Long-Term Debt Issuances for HLF hit a ceiling of $617.2 million in Q2 2024 and a floor of -$600.0 million in Q4 2021.
Historically, Long-Term Debt Issuances has averaged $55.2 million across 5 years, with a median of $79.5 million in 2022.
The widest YoY moves for Long-Term Debt Issuances: up 969.3% in 2024, down 257.67% in 2024.
Tracing HLF's Long-Term Debt Issuances over 5 years: stood at -$600.0 million in 2021, then increased by 27.83% to -$433.0 million in 2022, then surged by 149.7% to $215.2 million in 2023, then plummeted by 257.67% to -$339.3 million in 2024, then rose by 20.19% to -$270.8 million in 2025.
Business Quant data shows Long-Term Debt Issuances for HLF at -$270.8 million in Q3 2025, $205.8 million in Q2 2025, and $65.0 million in Q1 2025.